Rockefeller Capital Management L.P. Rigel Pharmaceuticals Inc Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.22 - $3.45 $2,220 - $3,450	-1,000 Reduced 48.73%	1,052 $3,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $868 - $1,313	-368 Reduced 15.21%	2,052 $5,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $1,750 - $2,250	-500 Reduced 17.12%	2,420 $8,000
Q1 2021 May 11, 2021	BUY	$3.35 - $4.93 $4,757 - $7,000	1,420 Added 94.67%	2,920 $9,000
Q3 2019 Nov 12, 2019	BUY	$1.63 - $2.62 $2,445 - $3,930	1,500 New	1,500 $3,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.